Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer

Radiology

Volumn 263, Issue 3, 2012, Pages 751-757

  Barrett, Tristan ^a,b   Vargas, Hebert Alberto ^a   Akin, Oguz ^a   Goldman, Debra A ^a   Hricak, Hedvig ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER SIZE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROSPECTIVE STUDY; SIGNAL DETECTION; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HEMORRHAGE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84862491162     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112100     Document Type: Article

References (14)

1. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195(2):385-390.
2. Bezzi M, Kressel HY, Allen KS, et al. Prostatic carcinoma: staging with MR imaging at 1.5 T. Radiology 1988;169(2):339-346.
3. Kaji Y, Kurhanewicz J, Hricak H, et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology 1998;206(3):785-790. (Pubitemid 28128531)
4. Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004;183(4):1079-1083. (Pubitemid 44185100)
5. Ahmed HU, Kirkham A, Arya M, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 2009;6(4):197-206.
6. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151(6):1571-1574. (Pubitemid 24151304)
7. Cabezas JS, Storme OA, Ramis C, Fruland BR, Kroll K, Larson TR. Initial human feasibility study of DC ablation as a treatment for benign prostatic hyperplasia: 6 month follow-up data. Conf Proc IEEE Eng Med Biol Soc 2010;2010:1609-1613.
8. Callea A, Piccinni R, Zizzi V, et al. High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression. Arch Ital Urol Androl 2010;82(4):253-255.
9. Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008;248(2):531-539.
10. Janssen MJ, Huijgens PC, Bouman AA, Oe PL, Donker AJ, van der Meulen J. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Transplant 1993;8(11):1228-1233. (Pubitemid 23342657)
11. Zakian KL, Shukla-Dave A, Ackerstaff E, Hricak H, Koutcher JA. 1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization. Cancer Biomark 2008;4(4-5):263-276.
12. Katz S, Rosen M. MR imaging and MR spectroscopy in prostate cancer management. Radiol Clin North Am 2006;44(5):723-734, viii. (Pubitemid 44498741)
13. Egawa S, Ohori M, Uchida T, Mashimo S, Kuwao S. Nodular hyperplasia in the peripheral zone of the prostate gland. Br J Urol 1994;74(4):520-521. (Pubitemid 24318236)
14. Rosenkrantz AB, Kopec M, Kong X, et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging 2010;31(6):1387-1394.